PharMerica (PMC) Tops Q1 EPS by 4c

PharMerica (NYSE: PMC) reported Q1 EPS of $0.37, $0.04 better than the analyst estimate of $0.33. Revenue for the quarter came in at $452.2 million versus the consensus estimate of $417.76 million.

PharMerica sees FY2014 EPS of $1.40-$1.50, versus prior guidance of $1.35-$1.5 and the consensus of $1.47. PharMerica sees FY2014 revenue of $1.70-1.75 billion, versus prior guidance of $1.67-1.72 billion and the consensus of $1.70 billion.

For earnings history and earnings-related data on PharMerica (PMC) click here.

You May Also Be Interested In

• Piper Sandler sees Google TPU sales hitting $104BN by 2028
• Zhibao Technology to acquire Malaysian AI computing firm Nexsys Tech
• BGC Group reaffirms Q3 2026 revenue and earnings outlook